Pathological role of interleukin-17 in poly I:C-induced hepatitis

PLoS One. 2013 Sep 19;8(9):e73909. doi: 10.1371/journal.pone.0073909. eCollection 2013.

Abstract

Immune-mediated responses were the main causes of liver damage during viral hepatitis, and recently viral RNA mimetic Poly I:C was used to induce a NK cell-dominated acute hepatitis. Interleukin-17A (IL-17A), the cytokine tightly associated with various autoimmune diseases, was known to play protective or pathological roles in LPS and ConA-induced hepatitis. However, its role in NK cell-mediated acute hepatitis remains unknown. Here we demonstrated that Poly I:C treatment triggered IL-17A production from hepatic γδT cells. Neutralizing IL-17A by monoclonal antibodies reduced Poly I:C-induced intrahepatic inflammatory responses and the liver injury through decreased accumulation, activation and cytolytic activity of NK cells in the liver. Furthermore, Poly I:C didn't trigger IL-17A secretion from γδT cells directly, and Kuppfer cells were demonstrated to be the accessory cell that can secrete IL-23. Finally, our findings demonstrated a pathological role of IL-17A and γδT cells in Poly I:C-induced acute hepatitis, which provides novel insights into viral infection-induced hepatitis and may serve as potential target in clinic immunotherapy against these disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Neutralizing / pharmacology
  • Female
  • Hepatitis, Animal / chemically induced
  • Hepatitis, Animal / immunology
  • Hepatitis, Animal / metabolism*
  • Interleukin-17 / antagonists & inhibitors
  • Interleukin-17 / immunology
  • Interleukin-17 / metabolism*
  • Killer Cells, Natural / immunology
  • Killer Cells, Natural / metabolism
  • Kupffer Cells / immunology
  • Kupffer Cells / metabolism
  • Liver / immunology
  • Liver / metabolism
  • Liver / pathology
  • Lymphocyte Activation / immunology
  • Lymphocyte Depletion
  • Male
  • Mice
  • Poly I-C / adverse effects
  • Receptors, Antigen, T-Cell, gamma-delta / metabolism
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocyte Subsets / metabolism

Substances

  • Antibodies, Monoclonal
  • Antibodies, Neutralizing
  • Interleukin-17
  • Receptors, Antigen, T-Cell, gamma-delta
  • Poly I-C

Grants and funding

This work was supported by 12th Five-Year Significant New Drugs Creation Plan of the Ministry of Science and Technology of China (No. 2011ZX09302-003-03), Medical Scientific Research Foundation of Zhejiang Province (Y2100347), the Opening Foundation of the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases (2010KF12), “11th Five-Year” Major Science and Technology Projects of Infectious Disease about AIDS and Viral Hepatitis (2008ZX10003011), and the National Natural Science Foundation of China (81072339). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.